Article

Personalized medicine in the genomic age of breast cancer

Author(s):

Debu Tripathy

We're not going to find one drug to treat everyone. That's why molecular medicine, or personalized medicine, has become so important in treating breast cancer, in fact - all cancers. And like all cancers, there will not be a one-size fits all treatment. Watch Dr. Tripathy's latest video blog to learn more:

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Minimally Invasive Surgery Transforms Lung Cancer Recovery
Image of man with text.
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Related Content
CURE spoke with experts about radical cystectomy for patients with bladder cancer: © stock.adobe.com.
August 2nd 2025

What Patients With Cancer Need to Know About Bladder Removal Surgery

Alex Biese
CURE spoke with experts about radical cystectomy, or surgical removal of the bladder, for patients with bladder cancer.
The Importance of Spotting Endometrial Cancer
August 2nd 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Image of man with text.
August 2nd 2025

Understanding Epithelioid Hemangioendothelioma: A Rare Vascular Cancer

Gina Mauro
Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, diagnosis, treatment options and more.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
August 2nd 2025

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
FDA sign.
August 2nd 2025

Oncolytic Virus Wins FDA Fast Track Designation in Soft Tissue Sarcoma

Ryan Scott
The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue sarcoma.
SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status: © stock.adobe.com.
August 2nd 2025

FDA Grants Orphan Drug Status to SAR446523 for Relapsed Myeloma

Spencer Feldman
SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for relapsed/refractory multiple myeloma.